Total Funding
72
30
Total FundingVenture - Series Unknown raised
Growth Score
-3 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
312560
Molecular Detection develops a portfolio of sample-to-answer molecular diagnostic tests for detecting infectious diseases.
Robert Citron: CFOPast Role: PricewaterhouseCoopers, Public Accountant
David Wilson: Vice President, Commercial Operations, EuropePast Role: Symphony Communication Services, Chief Financial Officer
About the Company
Molecular Detection Inc. (MDI) is developing and commercializing a portfolio of "sample-to-answer" Detect-Ready™ molecular diagnostic tests for the rapid detection of infectious diseases. The company is preparing to launch its first product, the Detect-Ready assay for the rapid detection of methicillin-resistant Staphylococcus aureus
(MRSA), a growing problem among hospitals and other health facilities around the globe.
